CA ATC S01BC10 · updated 2 Nov 2026
Nepafenac shortage in Canada
Is there a Nepafenac shortage in Canada?
Yes. As of 2 Nov 2026, 2 Nepafenac products are reported short in Canada, the first since 20 Jul 2026. The company estimate for the return is 30 Jun 2027. Main reason: active ingredient shortage.
Not reported short in any other country we track. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ILEVRO (1 bottle of 3 mL) | NOVARTIS PHARMACEUTICALS CANADA INC | 20 Jul 2026 | not given | Active ingredient shortage Shortage of an active ingredient |
| CA | ILEVRO (1 bottle of 3 mL) discontinuation | NOVARTIS PHARMACEUTICALS CANADA INC | not given | 30 Jun 2027 | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.